Physician profile
Stephen C Widman
NPI 1346278512
$3,270.30
in general payments reported to CMS, 2019-2025
18 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,444 · 2020: $40.21 · 2021: $126 · 2022: $15.05 · 2023: $165 · 2024: $151 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,568.58 | 2019 | |
| Siemens Medical Solutions USA, INC. | $503.24 | 2019 | |
| Ge Healthcare | $318.30 | 2019 | |
| Novartis Pharmaceuticals Corporation | $121.84 | 2023-2025 | |
| Shockwave Medical, INC | $110.64 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $106.15 | 2020-2025 | Impella |
| Medtronic, INC. | $88.78 | 2021 | |
| Edwards Lifesciences Corporation | $82.28 | 2025 | |
| Janssen Pharmaceuticals, INC | $60.72 | 2020-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $56.33 | 2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $55.34 | 2025 | Farapulse |
| Amgen INC. | $53.93 | 2019 | |
| Abbott Laboratories | $37.09 | 2021 | |
| Heartflow, INC. | $26.24 | 2023 | Ffrct |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.99 | 2023 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $24.36 | 2025 | Wegovy |
| Pfizer INC. | $17.93 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.56 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Widman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.